Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 24;6(3):e00396.
doi: 10.1002/prp2.396. eCollection 2018 Jun.

Machine Learning of Big Data in Gaining Insight Into Successful Treatment of Hypertension

Affiliations
Free PMC article

Machine Learning of Big Data in Gaining Insight Into Successful Treatment of Hypertension

Gideon Koren et al. Pharmacol Res Perspect. .
Free PMC article

Abstract

Despite effective medications, rates of uncontrolled hypertension remain high. Treatment protocols are largely based on randomized trials and meta-analyses of these studies. The objective of this study was to test the utility of machine learning of big data in gaining insight into the treatment of hypertension. We applied machine learning techniques such as decision trees and neural networks, to identify determinants that contribute to the success of hypertension drug treatment on a large set of patients. We also identified concomitant drugs not considered to have antihypertensive activity, which may contribute to lowering blood pressure (BP) control. Higher initial BP predicts lower success rates. Among the medication options and their combinations, treatment with beta blockers appears to be more commonly effective, which is not reflected in contemporary guidelines. Among numerous concomitant drugs taken by hypertensive patients, proton pump inhibitors (PPIs), and HMG CO-A reductase inhibitors (statins) significantly improved the success rate of hypertension. In conclusions, machine learning of big data is a novel method to identify effective antihypertensive therapy and for repurposing medications already on the market for new indications. Our results related to beta blockers, stemming from machine learning of a large and diverse set of big data, in contrast to the much narrower criteria for randomized clinic trials (RCTs), should be corroborated and affirmed by other methods, as they hold potential promise for an old class of drugs which may be presently underutilized. These previously unrecognized effects of PPIs and statins have been very recently identified as effective in lowering BP in preliminary clinical observations, lending credibility to our big data results.

Keywords: beta blockers; big data; hypertension; machine learning; protein pump inhibitors; statins.

Similar articles

See all similar articles

Cited by 2 articles

References

    1. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. http://apps.who.int/iris/handle/10665/79059. Accessed February 3, 2018.
    1. Kjeldsen S, Feldman RD, Lisheng L, et al. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014;6:2033‐2051. - PMC - PubMed
    1. Obermeyer Z, Emanuel EJ. Predicting the future—big data, machine learning, and clinical medicine. N Engl J Med. 2016;6:1216‐1219. - PMC - PubMed
    1. Goldshtein I, Shalev V, Zigman N, Chodick G, Levkovitch-Verbin H. The Maccabi Glaucoma Study: treatment patterns and persistence with glaucoma therapy in a large Israeli health maintenance organization. J Glaucoma. 2016;6:e386‐e391. - PubMed
    1. Hu TK. Random decision forests. 3rd International Conference on Document Analysis and Recognition. 1995.

MeSH terms

Substances

Feedback